Regulatory Updates
🌏 NMPA Page 7NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 73–84 of 87 articles
Fierce Pharma Asia: Major Developments in Oncology and Workforce Changes
Harmonization of Clinical Trial Regulations: PMDA, TGA & CDSCO Compared
NMPA Priority Review Pathway: Accelerating Innovative Drug Approvals in China
Biosimilar Regulation Japan: Aligning PMDA with EMA and FDA Guidelines
China NMPA Data Integrity: What Foreign Pharma Must Know for Approval
NMPA Data Integrity Compliance: What Foreign Pharma Must Know in APAC
SAKIGAKE Designation Japan: What You Need to Know About PMDA's Expedited Pathway
Duchesnay and PeriPharm Call for Regulatory Reform as Canadian Women Wait 3+ Years for Health Innovations
PMDA Approves Peripheral Rotablator PRO and Visual-ICE Cryoablation System Modifications in Japan
NMPA Expedited Approval Oncology: Impact on Cancer Drug Access in China
NMPA Priority Review Granted to AI Diagnostic Tool for Early Cancer Detection
NMPA Data Integrity: What Pharmaceutical Manufacturers Must Know